M. Nakou

Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.

D. Boumpas, G. Bertsias, P. Sidiropoulos, 2013, Clinical and experimental rheumatology.

Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures.

N. Knowlton, M. Centola, H. Papadaki, 2008, Arthritis and rheumatism.

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

H. Papadaki, D. Boumpas, G. Bertsias, 2009, Arthritis research & therapy.

Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression

D. Iliopoulos, M. Hatziapostolou, D. Boumpas, 2011, Annals of the rheumatic diseases.

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.

M. Tzardi, D. Kardassis, C. Mamalaki, 2009, Arthritis and rheumatism.

Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus

D. Iliopoulos, M. Hatziapostolou, M. Centola, 2010, PloS one.